Company News: Merck (MRK) posts Q4 EPS in line with analysts' estimates

Market news

2 February 2017

Company News: Merck (MRK) posts Q4 EPS in line with analysts' estimates

Merck reported Q4 FY 2016 earnings of $0.89 per share (versus $0.93 in Q4 FY 2015), in-line with analysts' consensus estimate.

The company's quarterly revenues amounted to $10.115 bln (-1% y/y), missing analysts' consensus estimate of $10.234 bln.

The company also issued downside guidance for FY 2017, projecting EPS of $3.72-3.87 (versus analysts' consensus estimate of $3.87) and revenues of $38.60-40.10 bln (versus analysts' consensus estimate of $40.19 bln).

MRK fell to $62.00 (-0.16%) in pre-market trading.

U.S.: Initial Jobless Claims, 246 (forecast 250)

The British pound fell after the Bank of England’s inflation report. GBP / USD lost about 150 pips and is currently trading at the $ 1.2559 level

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.